Nanome Webinar Series

 

The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights.

 

Tuesday, August 24th, 2021

10 am PST / 1 pm EST

RSVP Now

Guest Speaker

6abe93e5-a9d5-479a-8a9b-fb4c2da166ab_small

Woody Sherman

Chief Computational Scientist at Roivant Discovery, former CSO at Silicon Therapeutics

What will you learn?

Join our guest speaker and panelists for a discussion and Q&A about the role of virtual reality in maximizing insights.

What Roivant Discovery is doing with physics-driven drug design.

The importance of structure-based drug discovery.

Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design.